Airway Pharmacology and Treatment 2019
DOI: 10.1183/13993003.congress-2019.pa1655
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of therapeutic response to anti-IL5 treatment in severe eosinophilic asthma patients no responders to omalizumab

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles